v3.26.1
Cash, Cash Equivalents, and Investments
 3 Months Ended
Apr. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash, Cash Equivalents, and Investments Cash, Cash Equivalents, and Investments
Cash, cash equivalents, and investments consisted of the following as of the dates indicated (in thousands):

April 30, 2026January 31, 2026
Cash and cash equivalents:
Cash$57,231 $51,006 
Money market funds150,653 185,205 
Commercial paper996 1,191 
Total cash and cash equivalents$208,880 $237,402 
Available-for-sale investments:
   U.S. Treasury securities $61,440 $60,429 
   Commercial paper5,182 2,218 
   Corporate debt securities141,566 143,490 
U.S. Government agency securities26,889 26,299 
Total available-for-sale investments$235,077 $232,436 
The following tables summarize the amortized cost, net unrealized gains (losses), and fair value of the Company’s investments by significant investment category as of the dates indicated (in thousands). Gross realized gains or losses from sales of available-for-sale securities were not material for the three months ended April 30, 2026 and 2025.

April 30, 2026
Amortized CostUnrealized Gain (Loss), NetEstimated Fair Value
Available-for-sale investments:
U.S. Treasury securities$61,467 $(27)$61,440 
Commercial paper5,183 (1)5,182 
Corporate debt securities141,775 (209)141,566 
U.S. Government agency securities26,906 (17)26,889 
Total available-for-sale investments$235,331 $(254)$235,077 
January 31, 2026
Amortized CostUnrealized Gain (Loss), NetEstimated Fair Value
Available-for-sale investments:
U.S. Treasury securities$60,357 $72 $60,429 
Commercial paper2,218 — 2,218 
Corporate debt securities143,257 233 143,490 
U.S. Government agency securities26,283 16 26,299 
Total available-for-sale investments$232,115 $321 $232,436 

The following tables present the Company’s available-for-sale securities by contractual maturity date as of the dates indicated (in thousands):

April 30, 2026
Amortized Cost
Fair Value
Due within one year$139,776 $139,819 
Due between one to five years95,555 95,258 
Total$235,331 $235,077 
January 31, 2026
Amortized Cost
Fair Value
Due within one year$142,032 $142,237 
Due between one to five years90,083 90,199 
Total$232,115 $232,436 
As of April 30, 2026, there were 89 securities in an unrealized loss position with an aggregate fair value of $146.4 million, none of which were in a continuous unrealized loss position for more than 12 months. As of January 31, 2026, there were 43 securities in an unrealized loss position with an aggregate fair value of $64.6 million, none of which was in a continuous unrealized loss position for more than 12 months.

When evaluating investments for impairment, the Company reviews factors such as the extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company’s intent to sell, or whether it is more likely than not that the Company will be required to sell, the investment before recovery of the investment’s amortized cost. No impairment loss has been recorded on the securities included in the tables above, as the Company believes that any decrease in fair value of these securities is temporary and the Company expects to recover at least up to the initial cost of the investment for these securities. The Company has not recorded an allowance for credit losses, as the Company believes any such losses would not be material based on the high-grade credit rating for each of its marketable securities as of the end of each period.